Zebrafish models in neuropsychopharmacology and CNS drug discovery

British Journal of Pharmacology

Volumn 174, Issue 13, 2017, Pages 1925-1944

  Khan, Kanza M ^a   Collier, Adam D ^a,b   Meshalkina, Darya A ^b,c   Kysil, Elana V ^c   Khatsko, Sergey L ^d   Kolesnikova, Tatyana ^d   Morzherin, Yury Yu ^d   Warnick, Jason E ^b,e   Kalueff, Allan V ^b,c,d,f   Echevarria, David J ^a,b  

^a UNIVERSITY OF SOUTHERN MISSISSIPPI   (United States)

^b The International Zebrafish Neuroscience Research Consortium (ZNRC)   (United States)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^d URAL FEDERAL UNIVERSITY   (Russian Federation)

^e ARKANSAS TECH UNIVERSITY   (United States)

^f GUANGDONG OCEAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMPHETAMINE DERIVATIVE; ANTICONVULSIVE AGENT; COCAINE; NEUROLEPTIC AGENT; NICOTINE; PSYCHEDELIC AGENT; SEDATIVE AGENT; CENTRAL NERVOUS SYSTEM AGENTS;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL MODEL; ANXIETY DISORDER; AUTOMATION; CENTRAL NERVOUS SYSTEM; DEPRESSION; DRUG ABUSE; DRUG SCREENING; DRUG SENSITIVITY; DRUG TARGETING; EPILEPSY; GENETIC MODEL; GENETIC SCREENING; HIGH THROUGHPUT SCREENING; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSIS; REVIEW; ZEBRA FISH; ANIMAL; CENTRAL NERVOUS SYSTEM DISEASE; CHEMISTRY; DISEASE MODEL; DRUG DEVELOPMENT; MOLECULAR LIBRARY; PRECLINICAL STUDY; SYNTHESIS; THERAPEUTIC USE;

ANIMALS; CENTRAL NERVOUS SYSTEM AGENTS; CENTRAL NERVOUS SYSTEM DISEASES; DISEASE MODELS, ANIMAL; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; SMALL MOLECULE LIBRARIES; ZEBRAFISH;

EID: 85017091455     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.13754     Document Type: Review

References (273)

1. Abreu MS, Giacomini AC, Kalueff AV, Barcellos LJ (2016). The smell of “anxiety”: behavioral modulation by experimental anosmia in zebrafish. Physiol Behav 157: 67–71.
2. Ahmed T, Gilani A-H (2009). Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease. Pharmacol Biochem Behav 91: 554–559.
3. Ahrens MB, Orger MB, Robson DN, Li JM, Keller PJ (2013). Whole-brain functional imaging at cellular resolution using light-sheet microscopy. Nat Methods 10: 413–420.
4. Akhisaroglu M, Kurtuncu M, Manev H, Uz T (2005). Diurnal rhythms in quinpirole-induced locomotor behaviors and striatal D2/D3 receptor levels in mice. Pharmacol Biochem Behav 80: 371–377.
5. Akindipe T, Wilson D, Stein DJ (2014). Psychiatric disorders in individuals with methamphetamine dependence: prevalence and risk factors. Metab Brain Dis 29: 351–357.
6. Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E et al. (2015a). The Concise Guide to PHARMACOLOGY 2015/16: Overview. Br J Pharmacol 172: 5729–5743.
7. Alexander SPH, Cidlowski JA, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015b). The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors. Br J Pharmacol 172: 5956–5978.
8. Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E et al. (2015c). The Concise Guide to PHARMACOLOGY 2015/16: Transporters. Br J Pharmacol 172: 6110–6202.
9. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015d). The concise guide to PHARMACOLOGY 2015/16: Enzymes. Br J Pharmacol 172: 6024–6109.
10. Alfaro JM, Ripoll-Gómez J, Burgos JS (2011). Kainate administered to adult zebrafish causes seizures similar to those in rodent models. Eur J Neurosci 33: 1252–1255.
11. Alsop D, Vijayan M (2009). The zebrafish stress axis: molecular fallout from the teleost-specific genome duplication event. Gen Comp Endocrinol 161: 62–66.
12. Alsop D, Vijayan MM (2008). Development of the corticosteroid stress axis and receptor expression in zebrafish. Am J Physiol Regul Integr Comp Physiol 294: R711–R719.
13. American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders: DSM, 5.ed edn. Association A.P: Washington, D.C.
14. Amores A, Catchen J, Ferrara A, Fontenot Q, Postlethwait JH (2011). Genome evolution and meiotic maps by massively parallel dna sequencing: spotted gar, an outgroup for the teleost genome duplication. Genetics 188: 799–808.
15. Amsterdam A, Hopkins S (2006). Mutagenesis strategies in zebrafish for identifying genes involved in development and disease. Trends Genet 22: 473–478.
16. Andrea Galimberti C, Magri F, Copello F, Arbasino C, Cravello L, Casu M et al. (2005). Seizure frequency and cortisol and dehydroepiandrosterone sulfate (DHEAS) levels in women with epilepsy receiving antiepileptic drug treatment. Epilepsia 46: 517–523.
17. Anxiety Disorders Association of America. (2016). Website. [Online] Available from ADAA.org (accessed 12/19/2016).
18. Armstrong GAB, Liao M, You Z, Lissouba A, Chen BE, Drapeau P (2016). Homology directed knockin of point mutations in the zebrafish tardbp and fus genes in ALS using the CRISPR/Cas9 system. PLoS One 11: e0150188.
19. Arrenberg AB, Del Bene F, Baier H (2009). Optical control of zebrafish behavior with halorhodopsin. Proc Natl Acad Sci 106: 17968–17973.
20. Ashburn TT, Thor KB (2004). Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3: 673–683.
21. Babaei F, Hong TLC, Yeung K, Cheng SH, Lam YW (2016). Contrast-enhanced X-ray micro-computed tomography as a versatile method for anatomical studies of adult zebrafish. Zebrafish 13: 310–316.
22. Babin PJ, Thisse C, Durliat M, Andre M, Akimenko M-A, Thisse B (1997). Both apolipoprotein E and A-I genes are present in a nonmammalian vertebrate and are highly expressed during embryonic development. Proc Natl Acad Sci 94: 8622–8627.
23. Baraban SC, Dinday MT, Hortopan GA (2013). Drug screening in Scn1a mutant zebrafish identifies clemzole as a potential Dravet syndrome treatment. Nat Commun 4: 2410.
24. Baraban SC, Taylor MR, Castro PA, Baier H (2005). Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 131: 759–768.
25. Barr AM, Markou A (2005). Psychostimulant withdrawal as an inducing condition in animal models of depression. Neurosci Biobehav Rev 29: 675–706.
26. Barros TP, Alderton WK, Reynolds HM, Roach AG, Berghmans S (2008). Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery. Br J Pharmacol 154: 1400–1413.
27. Baxendale S, Holdsworth CJ, Santoscoy PLM, Harrison MRM, Fox J, Parkin A et al. (2012). Identification of compounds with anti-convulsant properties in a zebrafish model of epileptic seizures. Dis Model Mech 5: 773–784.
28. Belanoff JK, Gross K, Yager A, Schatzberg AF (2001). Corticosteroids and cognition. J Psychiatr Res 35: 127–145.
29. Bell E, Klimova TA, Eisenbart J, Moraes CT, Murphy MP, Buinger GRS et al. (2007). The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J Cell Biol 177: 1029–1036.
30. Bencan Z, Sledge D, Levin ED (2009). Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. Pharmacol Biochem Behav 94: 75–80.
31. Berk M, Malhi GS, Gray LJ, Dean OM (2013). The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci 34: 167–177.
32. Blaker-Lee A, Gupta S, McCammon JM, De Rienzo G, Sive HL (2012). Zebrafish homologs of genes within 16p11.2, a genomic region associated with brain disorders, are active during brain development, and include two deletion dosage sensor genes. Dis Model Mech 5: 834–851.
33. Blaser R, Vira D (2014). Experiments on learning in zebrafish (Danio rerio): a promising model of neurocognitive function. Neurosci Biobehav Rev 42: 224–231.
34. Braff DL, Geyer MA, Swerdlow NR (2001). Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156: 234–258.
35. Brennan CH (2011). Zebrafish behavioural assays of translational relevance for the study of psychiatric disease. Rev Neurosci 22: 37–48.
36. Brown C, Schulberg HC, Madonia MJ, Shear MK, Houck PR (1996). Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 153: 1293–1300.
37. Bruni G, Rennekamp AJ, Velenich A, McCarroll M, Gendelev L, Fertsch E et al. (2016). Zebrafish behavioral profiling identifies multitarget antipsychotic-like compounds. Nat Chem Biol 12: 559–566.
38. Buffalari DM, See RE (2010). Amygdala mechanisms of Pavlovian psychostimulant conditioning and relapse. In: Behavioral Neuroscience of Drug Addiction. Springer: Berlin, pp. 73–99.
39. Burgess HA, Granato M (2007). Sensorimotor gating in larval zebrafish. J Neurosci 27: 4984–4994.
40. Bystritsky A (2006). Treatment-resistant anxiety disorders. Mol Psychiatry 11: 805–814.
41. Cachat JM, Canavello PR, Elegante MF, Bartels BK, Hart PC, Bergner CL et al. (2011a). Modeling withdrawal syndrome in zebrafish. Behav Brain Res 208: 371–376.
42. Cachat JM, Stewart A, Utterback E, Hart P, Gaikwad S, Wong K et al. (2011b). Three-dimensional neurophenotyping of adult zebrafish behavior. PLoS One 6: e17597.
43. Campbell WA, Yang H, Zetterberg H, Baulac S, Sears JA, Liu T et al. (2006). Zebrafish lacking Alzheimer presenilin enhancer 2 (Pen-2) demonstrate excessive p53-dependent apoptosis and neuronal loss. J Neurochem 96: 1423–1440.
44. Canavello PR, Cachat JM, Beeson EC, Laffoon AL, Grimes C, Haymore WA et al. (2011). Measuring endocrine (cortisol) responses of zebrafish to stress. In: Zebrafish neurobehavioral protocols. Humana Press: Totowa, NJ, pp. 135–142.
45. Carvill GL, Weckhuysen S, McMahon JM, Hartmann C, Moller RS, Hjalgrim H et al. (2014). GABRA1 and STXBP1: novel genetic causes of Dravet syndrome. Neurology 82: 1245–1253.
46. Caspi A, Moffitt TE (2006). Gene–environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 7: 583–590.
47. Cheng Y-C, Scotting PJ, Hsu L-S, Lin S-J, Shih H-Y, Hsieh F-Y et al. (2013). Zebrafish rgs4 is essential for motility and axonogenesis mediated by Akt signaling. Cell Mol Life Sci 70: 935–950.
48. Ciura S, Lattante S, Le Ber I, Latouche M, Tostivint H, Brice A et al. (2013). Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann Neurol 74: 180–187.
49. Cognato GP, Bortolotto JW, Blazina AR, Christoff RR, Lara DR, Vianna MR et al. (2012). Y-Maze memory task in zebrafish (Danio rerio): the role of glutamatergic and cholinergic systems on the acquisition and consolidation periods. Neurobiol Learn Mem 98: 321–328.
50. Collier AD, Echevarria DJ (2013). The utility of the zebrafish model in conditioned place preference to assess the rewarding effects of drugs. Behav Pharmacol 24: 375–383.
51. Collier AD, Khan KM, Caramillo EM, Mohn RS, Echevarria DJ (2014). Zebrafish and conditioned place preference: a translational model of drug reward. Prog Neuropsychopharmacol Biol Psychiatry 55: 16–25.
52. Colwill RM, Raymond J, Ferreira L, Escudero H (2005). Visual discrimination learning in zebrafish (Danio rerio). Behav Processes 70: 19–31.
53. Conklin EE, Lee KL, Schlabach SA, Woods IG (2015). VideoHacking: automated tracking and quantification of locomotor behavior with open source software and off-the-shelf video equipment. J Undergraduate Neurosci Educ 13: A120–A125.
54. Cortese BM, Phan KL (2005). The role of glutamate in anxiety and related disorders. CNS Spectr 10: 820–830.
55. Cryan JF, Holmes A (2005). The ascent of mouse: advances in modelling human depression and anxiety. Nat Rev Drug Discov 4: 775–790.
56. Cunliffe VT (2015). Building a zebrafish toolkit for investigating the pathobiology of epilepsy and identifying new treatments for epileptic seizures. J Neurosci Methods 260: 91–95.
57. Cunliffe VT (2016). Building a zebrafish toolkit for investigating the pathobiology of epilepsy and identifying new treatments for epileptic seizures. J Neurosci Methods 260: 91–95.
58. Cunliffe VT, Baines RA, Giachello CNG, Lin W-H, Morgan A, Reuber M et al. (2015). Epilepsy research methods update: understanding the causes of epileptic seizures and identifying new treatments using non-mammalian model organisms. Seizure 24: 44–51.
59. Cutler C, Multani P, Robbins D, Kim HT, Le T, Hoggatt J et al. (2013). Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation. Blood 122: 3074–3081.
60. Danilova NP, Krupnik VE, Sugden D, Zhdanova I (2004). Melatonin stimulates cell proliferation in zebrafish embryo and accelerates its development. FASEB J 18: 751–753.
61. Darland T, Dowling JE (2001). Behavioral screening for cocaine sensitivity in mutagenized zebrafish. Proc Natl Acad Sci 98: 11691–11696.
62. De Campos EG, Bruni AT, De Martinis BS (2015). Ketamine induces anxiolytic effects in adult zebrafish: a multivariate statistics approach. Behav Brain Res 292: 537–546.
63. de Rienzo G, Gutzman JH, Sive HL (2012). Efficient shRNA-mediated inhibition of gene expression in zebrafish. Zebrafish 9: 97–107.
64. Dean OM, Giorlando F, Berk M (2011). N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. J Psychiatry Neurosci 36: 78–86.
65. Desmond D, Kyzar E, Gaikwad S, Green J, Riehl R, Roth A et al. (2012). Assessing epilepsy-related behavioral phenotypes in adult zebrafish. In: Zebrafish Protocols for Neurobehavioral Research, Humana Press: New York, pp. 313–322.
66. Deussing JM (2006). Animal models of depression. Drug Discov Today Dis Model 3: 375–383.
67. Douglass AD, Kraves S, Deisseroth K, Schier AF, Engert F (2008). Escape behavior elicited by single, channelrhodopsin-2-evoked spikes in zebrafish somatosensory neurons. Curr Biol 18: 1133–1137.
68. Ek F, Malo M, Åberg Andersson M, Wedding C, Kronborg J, Svensson P et al. (2016). Behavioral analysis of dopaminergic activation in zebrafish and rats reveals similar phenotypes. ACS Chem Nerosci 7: 633–646.
69. Engel J (2013). Seizures and epilepsy, Vol. 83. Oxford University Press: New York.
70. Félix AS, Faustino AI, Cabral EM, Oliveira RF (2013). Noninvasive measurement of steroid hormones in zebrafish holding-water. Zebrafish 10: 110–115.
71. Fetcho J, O'Malley DM (1995). Visualization of active neural circuitry in the spinal cord of intact zebrafish. J Neurophysiol 73: 399–406.
72. Fibiger HC (1991). Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci 14: 220–223.
73. Fonseka TM, Wen XY, Foster JA, Kennedy SH (2016). Zebrafish models of major depressive disorders. J Neurosci Res 94: 3–14.
74. Friedrich RW, Jacobson GA, Zhu P (2010). Circuit neuroscience in zebrafish. Curr Biol 20: R371–R381.
75. Froyset AK, Khan EA, Fladmark KE (2016). Quantitative proteomics analysis of zebrafish exposed to sub-lethal dosages of β-methyl-amino-L-alanine (BMAA). Sci Rep 1–6.
76. Fulcher N, Tran S, Shams S, Chatterjee D, Gerlai R (2017). Neurochemical and behavioral responses to unpredictable chronic mild stress following developmental isolation: the zebrafish as a model for major depression. Zebrafish 14: 23–34.
77. Fumagalli F, Molteni R, Racagni G, Riva MA (2007). Stress during development: impact on neuroplasticity and relevance to psychopathology. Prog Neurobiol 81: 197–217.
78. Furmark T, Tillfors M, Garpenstrand H, Marteinsdottir I, Långström B, Oreland L et al. (2004). Serotonin transporter polymorphism related to amygdala excitability and symptom severity in patients with social phobia. Neurosci Lett 362: 189–192.
79. Galecki P, Talarowska M, Bobińska K, Szemraj J (2014). COX-2 gene expression is correlated with cognitive function in recurrent depressive disorder. Psychiatry Res 215: 488–490.
80. Garakani A, Mathew S, Charney DS (2006). Neurobiology of anxiety disorders and implications for treatment. Mt Sinai J Med 73: 941–949.
81. Gerlai R (2013). Antipredatory behavior of zebrafish: adaptive function and a tool for translational research. Evol Psychol 11: 591–605.
82. Gerlai R (2014). Social behavior of zebrafish: from synthetic images to biological mechanisms of shoaling. J Neurosci Methods 234: 59–65.
83. Gerlai R (2016). Learning and memory in zebrafish (Danio rerio). Methods Cell Biol 134: 551–586.
84. Gerlai R, Lahav M, Guo S, Rosenthal A (2000). Drinks like a fish: zebra fish (Danio rerio) as a behavior genetic model to study alcohol effects. Pharmacol Biochem Behav 67: 773–782.
85. Gerlai R, Lee V, Blaser RE (2006). Effects of acute and chronic ethanol exposure on the behavior of adult zebrafish (Danio rerio). Pharmacol Biochem Behav 85: 752–761.
86. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 156: 117–154.
87. Giacomini NJ, Rose B, Kobayashi K, Guo S (2006). Antipsychotics produce locomotor impairment in larval zebrafish. Neurotoxicol Teratol 28: 245–250.
88. Goessling W, Allen RS, Guan X, Jin P, Uchida N, Dovey N et al. (2011). Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models. Cell Stem Cell 8: 445–458.
89. Goldshmit Y, Sztal TE, Jusuf PR, Hall TE, Nguyen-Chi M, Currie PD (2012). Fgf-dependent glial cell bridges facilitate spinal cord regeneration in zebrafish. J Neurosci 32: 7477–7492.
90. Green J, Collins C, Kyzar EJ, Pham M, Roth A, Gaikwad S et al. (2012). Automated high-throughput neurophenotyping of zebrafish social behavior. J Neurosci Methods 210: 266–271.
91. Griebel G, Holmes A (2013). 50 years of hurdles and hope in anxiolytic drug discovery. Nat Rev Drug Discov 12: 667–687.
92. Griffiths BB, Schoonheim PJ, Ziv L, Voelker L, Baier H, Gahtan E (2012a). A zebrafish model of glucocorticoid resistance shows serotonergic modulation of the stress response. Front Behav Neurosci 6: 1–10.
93. Griffiths BB, Schoonheim PJ, Ziv L, Voelker L, Baier H, Gahtan E (2012b). A zebrafish model of glucocorticoid resistance shows serotonergic modulation of the stress response. Front Behav Neurosci 6: 68.
94. Grone BP, Baraban SC (2015). Animal models in epilepsy research: legacies and new directions. Nat Neurosci 18: 339–343.
95. Grone BP, Marchese M, Hamling KR, Kumar MG, Krasniak CS, Sicca F et al. (2016). Epilepsy, behavioral abnormalities, and physiological comorbidities in syntaxin-binding protein 1 (STXBP1) mutant zebrafish. PLoS One 11: e0151148.
96. Gupta (2014). Assessment of locomotion behavior in adult zebrafish after acute exposure to different pharmacological reference compounds. Drug Development and Therapeutics 127–133.
97. Haesemeyer M, Schier AF (2015). The study of psychiatric disease genes and drugs in zebrafish. Curr Opin Neurobiol 30: 122–130.
98. Havsteen BH (2002). The biochemistry and medical significance of the flavonoids. Pharmacol Ther 96: 67–202.
99. Hek K, Direk N, Newson RS, Hofman A, Hoogendijk WJ, Mulder CL et al. (2013). Anxiety disorders and salivary cortisol levels in older adults: a population-based study. Psychoneuroendocrinology 38: 300–305.
100. Herbert J (2013). Cortisol and depression: three questions for psychiatry. Psychol Med 43: 449–469.
101. Hikida T, Kitabatake Y, Pastan I, Nakanishi S (2003). Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc Natl Acad Sci 100: 6169–6173.
102. Holsboer F (2001). Stress, hypercortisolism and corticosteroid receptors in depression: implicatons for therapy. J Affect Disord 62: 77–91.
103. Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M et al. (2013). The zebrafish reference genome sequence and its relationship to the human genome. Nature 496: 498–503.
104. Howell KR, Kutiyanawalla A, Pillai A (2011). Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex. PLoS One 6: e20198.
105. Hwang WY, Fu Y, Reyon D, Maeder ML, Tsai SQ, Sander JD et al. (2013). Efficient genome editing in zebrafish using a CRISPR-Cas system. Nat Biotechnol 31: 227–229.
106. Idalencio R, Kalichak F, Rosa JGS, de Oliveira TA, Koakoski G, Gusso D et al. (2015). Waterborne risperidone decreases stress response in zebrafish. PLoS One 10: e0140800.
107. Insel TR, Voon V, Nye JS, Brown VJ, Altevogt BM, Bullmore ET et al. (2011). Innovative solutions to novel drug development in mental health. Neurosci Biobehav Rev 37.
108. Irons T, Kelly P, Hunter D, Macphail R, Padilla S (2013). Acute administration of dopaminergic drugs has differential effects on locomotion in larval zebrafish. Pharmacol Biochem Behav 103: 792–813.
109. Jesuthasan S (2012). Fear, anxiety, and control in the zebrafish. Dev Neurobiol 72: 395–403.
110. Jones LJ, Norton W (2015). Using zebrafish to uncover the genetic and neural basis of aggression, a frequent comorbid symptom of psychiatric disorders. Behav Brain Res 276: 171–180.
111. Kalueff AV, Echevarria DJ, Stewart AM (2014a). Gaining translational momentum: more zebrafish models for neuroscience research. Prog Neuropsychopharmacol Biol Psychiatry 55: 1–6.
112. Kalueff AV, Gebhardt M, Stewart AM, Cachat JM, Brimmer M, Chawla JS et al. (2013). Towards a comprehensive catalog of zebrafish behavior 1.0 and beyond. Zebrafish 10: 70–86.
113. Kalueff AV, Stewart AM, Gerlai R (2014b). Zebrafish as an emerging model for studying complex brain disorders. Trends Pharmacol Sci 35: 63–75.
114. Kane J, Honigfeld G, Singer J, Meltzer H (1988). Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45: 789–796.
115. Kasher PR, Namavar Y, van Tjin P, Fluiter K, Sizarov A, Kamermans M et al. (2011). Impairment of the tRNA-splicing endonuclease subunit 54 (tsen54) gene causes neurological abnormalities and larval death in zebrafish models of pontocerebellar hypoplasia. Hum Mol Genet 20: 1574–1580.
116. Kaslin J, Panula P (2001). Comparative anatomy of the histaminergic and other aminergic systems in zebrafish (Danio rerio). J Comp Neurol 440: 342–377.
117. Keedwell PA, Poon L, Papadopoulos AS, Marshall E, Checkley SA (2001). Salivary cortisol measurements during a medically assisted alcohol withdrawal. Addict Biol 6: 247–257.
118. Keifer J, Summers CH (2016). Putting the “Biology” back into “Neurobiology”: the strength of diversity in animal model systems for neuroscience research. Front Syst Neurosci 10: 69.
119. Kendler KS, Aggen SH, Neale MC (2013). Evidence for multiple genetic factors underlying DSM-IV criteria for major depression. JAMA Psychiat 70: 599–607.
120. Kessler RC (2007). The global burden of anxiety and mood disorders: putting ESEMeD findings into perspective. J Clin Psychiatry 68: 10–19.
121. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005). Prevalence severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 617–627.
122. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardimn O et al. (2011). Amyotrophic lateral sclerosis. Lancet 377: 942–955.
123. Kily LJ, Cowe YCM, Hussain O, Patel S, McElwaine S, Cotter FE et al. (2008). Gene expression changes in a zebrafish model of drug dependency suggest conservation of neuro-adaptation pathways. J Exp Biol 211: 1623–1634.
124. Kim Y-H, Lee Y, Kim D, Jung MW, Lee C-J (2010). Scopolamine-induced learning impairment reversed by physostigmine in zebrafish. Neurosci Res 67: 156–161.
125. Knafo S, Wyart C (2015). Optogenetic neuromodulation: new tools for monitoring and breaking neural circuits. Ann Phys Rehabil Med 58: 259–264.
126. Kok FO, Shin M, Ni C-W, Gupta A, Grosse AS, van Impel A et al. (2015). Reverse genetic screening reveals poor correlation between morpholino-induced and mutant phenotypes in zebrafish. Dev Cell 31: 97–108.
127. Kokel D, Bryan J, Laggner C, White R, Cheung CYJ, Mateus R et al. (2010). Rapid behavior-based identification of neuroactive small molecules in the zebrafish. Nat Chem Biol 6: 231–237.
128. Koob GF (1992). Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13: 177–184.
129. Korte S (2001). Corticosteroids in relation to fear, anxiety and psychopathology. Neurosci Biobehav Rev 25: 117–142.
130. Krishnan V, Nestler EJ (2011). Animal models of depression: molecular perspectives. Curr Top Behav Neurosci 7: 121–147.
131. Kubo F, Hablitzel B, Dal Maschio M, Driever W, Baier H, Arrenberg AB (2014). Functional architecture of an optic flow-responsive area that drives horizontal eye movements in zebrafish. Neuron 81: 1344–1359.
132. Kumari V, Soni W, Sharma T (1999). Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry 156: 1046–1051.
133. Kyzar E, Stewart AM, Landsman S, Collins C, Gebhardt M, Robinson K et al. (2014). Behavioral effects of bidirectional modulation of brain monoamines by reserpine and d-amphetamine in zebrafish. Brain Res 1527: 108–116.
134. Kyzar EJ, Kalueff AV (2016). Exploring hallucinogen pharmacology and psychedelic medicine with zebrafish models. Zebrafish 13: 379–390.
135. Lara DR, Souza DO (2000). Schizophrenia: a purinergic hypothesis. Med Hypotheses 54: 157–166.
136. Lau B, Bretaud S, Huang Y, Lin E, Guo S (2006). Dissociation of food and opiate preference by a genetic mutation in zebrafish. Genes Brain Behav 5: 497–505.
137. Levin ED, Bencan Z, Cerutti DT (2007). Anxiolytic effects of nicotine in zebrafish. Physiol Behav 90: 54–58.
138. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO et al. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353: 1209–1223.
139. Ljunggren EE, Haupt S, Ausborn J, Ampatzis K, El Manira A (2014). Optogenetic activation of excitatory premotor interneurons is sufficient to generate coordinated locomotor activity in larval zebrafish. J Neurosci 34: 134–139.
140. Loebrich S, Nedivi E (2009). The function of activity-regulated genes in the nervous system. Physiol Rev 89: 1079–1103.
141. Lombardo S, Maskos U (2015). Role of the nicotinic acetylcholine receptor in Alzheimer's disease pathology and treatment. Neuropharmacology 96: 255–262.
142. López-Patiño M, Yu L, Cabral EM, Zhdanova I (2008). Anxiogenic effects of cocaine withdrawal in zebrafish. Physiol Behav 93: 160–171.
143. Lovallo WR (2006). Cortisol secretion patterns in addiction and addiction risk. Int J Psychophysiol 59: 195–202.
144. Love DR, Pichler FB, Dodd A, Copp BR, Greenwood DR (2004). Technology for high-throughput screens: the present and future using zebrafish. Curr Opin Biotechnol 15: 564–571.
145. Lucassen P, Oomen C, Schouten M, Encinas J, Fitzsimons C (2016). Adult neurogenesis, chronic stress and depression. In: Adult Neurogenesis in the Hippocampus: Health, Psychopathology, and Brain Disease. Academic Press, Elsevier: Amsterdam p. 177–206.
146. Lucke-Wold B (2011). The varied uses of conditioned place preference in behavioral neuroscience research: an investigation of alcohol administration in model organisms. Impulse (Columbia, SC) 2011, 1–13.
147. Lundegaard PR, Anastasaki C, Grant NJ, Sillito RR, Zich J, Zeng Z et al. (2015). MEK inhibitors reverse cAMP-mediated anxiety in zebrafish. Chem Biol 22: 1335–1346.
148. Magno LDP, Fontes A, Gonçalves BMN, Gouveia A (2015). Pharmacological study of the light/dark preference test in zebrafish (Danio rerio): waterborne administration. Pharmacol Biochem Behav 135: 169–176.
149. Mahmood F, Fu S, Cooke J, Wilson SW, Cooper JD, Russell C (2013). A zebrafish model of CLN2 disease is deficient in tripeptidyl peptidase 1 and displays progressive neurodegeneration accompanied by a reduction in proliferation. Brain 136: 1488–1507.
150. Marcon M, Herrmann AP, Mocelin R, Rambo CL, Koakoski G, Abreu MS et al. (2016). Prevention of unpredictable chronic stress-related phenomena in zebrafish exposed to bromazepam, fluoxetine and nortriptyline. Psychopharmacology (Berl) 233: 3815–3824.
151. Martín I, Gómez A, Salas C, Puerto A, Rodríguez F (2011). Dorsomedial pallium lesions impair taste aversion learning in goldfish. Neurobiol Learn Mem 96: 297–305.
152. Mathur P, Berberoglu MA, Guo S (2011). Preferene for ethanol in zebrafish following a single exposure. Behav Brain Res 217: 128–133.
153. Mathur P, Guo S (2010). Use of zebrafish as a model to understand mechanisms of addiction and complex neurobehavioral phenotypes. Neurobiol Dis 40: 66–72.
154. Maximino C, Herculano AM (2010). A review of monoaminergic neuropsychopharmacology in zebrafish. Zebrafish 7: 359–378.
155. McCammon JM, Sive H (2015). Challenges in understanding psychiatric disorders and developing therapeutics: a role for zebrafish. Dis Model Mech 8: 647–656.
156. McCarroll M, Gendelev L, Keiser M, Kokel D (2016). Leveraging large-scale behavioral profiling in zebrafish to explore neuroactive polypharmacology. ASC Chem Biol 11: 842–849.
157. McGown A, McDearmid JR, Panagiotaki N, Tong H, Al Mashhadi S, Redhead N et al. (2013). Early interneuron dysfunction in ALS: insights from a mutant sod1 zebrafish model. Ann Neurol 73: 246–258.
158. Mead AN, Vasilaki A, Spyraki C, Duka T, Stephens DN (1999). AMPA-receptor involvement in c-fos expression in the medial prefrontal cortex and amygdala dissociates neural substrates of conditioned activity and conditioned reward. Eur J Neurosci 11: 4089–4098.
159. Merritt K, McGuire P, Egerton A (2013). Relationship between glutamate dysfunction and symptoms and cognitive function in psychosis. Front Psych 86–93.
160. Meyer A, Schartl M (1999). Gene and genome duplications in vertebrates: the one-to-four (-to-eight in fish) rule and the evolution of novel gene functions. Curr Opin Cell Biol 11: 699–704.
161. Mi G, Gao Y, Yan H, Jin X, Ye E, Liu S et al. (2016). l-Scoulerine attenuates behavioural changes induced by methamphetamine in zebrafish and mice. Behav Brain Res 298: 97–104.
162. Miyamoto S, Duncan GE, Marx CE, Lieberman JA (2005). Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol Psychiatry 10: 79–104.
163. Mobini S, Chiang T-J, Ho M-Y, Bradshaw C, Szabadi E (2000). Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat. Psychopharmacology (Berl) 152: 47–54.
164. Mocelin R, Herrmann AP, Marcon M, Rambo CL, Rohden A, Bevilaqua F et al. (2015). N-acetylcysteine prevents stress-induced anxiety behavior in zebrafish. Pharmacol Biochem Behav 139: 121–126.
165. Moghaddam B, Jackson ME (2003). Glutamatergic animal models of schizophrenia. Ann N Y Acad Sci 1003: 131–137.
166. Moussavi Nik SH, Croft K, Mori TA, Lardelli M (2014). The comparison of methods for measuring oxidative stress in zebrafish brains. Zebrafish 11: 248–254.
167. Moussavi Nik SH, Newman M, Lardelli M (2011). The response of HMGA1 to changes in oxygen availability is evolutionarily conserved. Exp Cell Res 317: 1503–1512.
168. Mueller T, Dong Z, Berberoglu MA, Guo S (2011). The dorsal pallium in zebrafish, Danio rerio (Cyprinidae, Teleostei). Brain Res 1381: 95–105.
169. Mueller T, Wullimann M (2015). Atlas of early Zebrafish Brain Development: A Tool for Molecular Neurogenetics. Academic Press: Amsterdam, Netherlands.
170. Nasevicius A, Ekker SC (2000). Effective targeted gene ‘knockdown’ in zebrafish. Nat Genet 26: 216–220.
171. Nestler EJ (2013). The origins of molecular psychiatry. J Mol Psychiatry 1: 1–2.
172. Newman M, Verdile G, Martins RN, Lardelli M (2011). Zebrafish as a tool in Alzheimer's disease research. Biochim Biophys Acta (BBA) - Mol Basis Dis 1812: 346–352.
173. Nguyen M, Stewart AM, Kalueff AV (2014). Aquatic blues: modeling depression and antidepressant action in zebrafish. Prog Neuropsychopharmacol Biol Psychiatry 55: 26–39.
174. Ninkovic J, Bally-Cuif L (2006). The zebrafish as a model system for assessing the reinforcing properties of drugs of abuse. Methods 39: 262–274.
175. Ninkovic J, Folchert A, Makhankov YV, Neuhauss SCF, Sillaber I, Straehle U et al. (2006). Genetic identification of AChE as a positive modulator of addiction to the psychostimulant D-amphetamine in zebrafish. J Neurobiol 66: 463–475.
176. Noldus LP (2016a). Daniovision. Retrieved from http://www.noldus.com/animal-behavior-research/products/daniovision (accessed 2/8/2016).
177. Noldus LP (2016b). Shoaling behavior in zebrafish. Retrieved from http://www.noldus.com/animal-behaviorresearch/solutions/research-fish/shoaling-behavior (accessed 2/8/2016).
178. Nornes S, Casper G, Esther C, Ey P, Lardelli M (2003). Developmental control of Presenilin1 expression, endoproteolysis, and interaction in zebrafish embryos. Exp Cell Res 289: 124–132.
179. Nornes S, Newman M, Wells S, Verdile G, Martins RN, Lardelli M (2009). Independent and cooperative action of Psen2 with Psen1 in zebrafish embryos. Exp Cell Res 315: 2791–2801.
180. North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, Lord AM et al. (2007). Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 447: 1007–1011.
181. Northcutt RG (2008). Forebrain evolution in bony fishes. Brain Res Bull 18: 191–205.
182. Orger MB, Portugues R (2016). Correlating whole brain neural activity with behavior in head-fixed larval zebrafish. Methods Mol Biol (Clifton, NJ) 1451: 307.
183. Otto MW, Pollack MH, Sachs GS, Reiter SR, Meltzer-Brody S, Rosenbaum JF (1993). Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder. Am J Psychiatry 150: 1485–1490.
184. Pando M, Sassone-Corsi P (2002). Unraveling the mechanisms of the vertebrate circadian clock: zebrafish may light the way. Bioessays 24: 419–426.
185. Pannia E, Tran S, Rampersad M, Gerlai R (2014). Acute ethanol exposure induces behavioural differences in two zebrafish (Danio rerio) strains: a time course analysis. Behav Brain Res 259: 174–185.
186. Panula P, Chen Y-C, Priyadarshini M, Kudo H, Semenova S, Sundvik M et al. (2010). The comparative neuroanatomy and neurochemistry of zebrafish CNS systems of relevance to human neuropsychiatric diseases. Neurobiol Dis 40: 46–57.
187. Panula P, Sallinen V, Sundvik M, Kolehmainen J, Torkko V, Tiittula A et al. (2006). Modulatory neurotransmitter systems and behavior: towards zebrafish models of neurodegenerative diseases. Zebrafish 3: 235–247.
188. Park E, Lee Y, Kim YK, Lee CJ (2008). Cholinergic modulation of neural activity in the telencephalon of the zebrafish. Neurosci Lett 439: 79–83.
189. Parker MO, Brock AJ, Walton RT, Brennan CH (2013). The role of zebrafish (Danio rerio) in dissecting the genetics and neural circuits of executive function. Front Neural Circuits 7: 1–13.
190. Pavlidis M, Sundvik M, Chen Y-C, Panula P (2011). Adaptive changes in zebrafish brain in dominant–subordinate behavioral context. Behav Brain Res 225: 529–537.
191. Pavlidis M, Theodoridi A, Tsalafouta A (2015). Neuroendocrine regulation of the stress response in adult zebrafish, Danio rerio. Prog Neuropsychopharmacol Biol Psychiatry 60: 121–131.
192. Pérez-Escudero A, Vicente-Page J, Hinz RC, Arganda S, de Polavieja GG (2014). idTracker: tracking individuals in a group by automatic identification of unmarked animals. Nat Methods 11: 743–748.
193. Perry EK, Tomlinson BE, Blessed G, Bergmann K, Gibson PH, Perry RH (1978). Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br Med J 2: 1457–1459.
194. Petzold AM, Balciunas D, Sivasubbu S, Clark KJ, Bedell VM, Westcot SE et al. (2009). Nicotine response genetics in the zebrafish. Proc Natl Acad Sci 106: 18662–18667.
195. Piato AL, Capiotti KM, Tamborski AR, Oses JP, Barcellos LJG, Bogo MR et al. (2011). Unpredictable chronic stress model in zebrafish (Danio rerio): behavioral and physiological responses. Prog Neuropsychopharmacol Biol Psychiatry 35: 561–567.
196. Plaut I (2000). Effects of fin size on swimming performace, swimming behaviour and routine activity of zebrafish Danio rerio. J Exp Biol 203: 813–820.
197. Porsolt RD (2000). Animal models of depression: utility for transgenic research. Rev Neurosci 11: 53–58.
198. Portavella M, Torres B, Salas C (2004). Avoidance response in goldfish: emotional and temporal involvement of medial and lateral telencephalic pallium. J Neurosci 24: 2335–2342.
199. Purdie EL, Samsudin S, Eddy FB, Codd GA (2009). Effects of the cyanobacterial neurotoxin β-N-methylamino-L-alanine on the early life stage development of zebrafish (Danio rerio). Aquat Toxicol 95: 279–284.
200. Purushothaman S, Saxena S, Meghah V, Lakshmi M, Singh SK, Brahmendra Swamy CV et al. (2015). Proteomic and gene expression analysis of zebrafish brain undergoing continuous light/dark stress. J Sleep Res 24: 458–465.
201. Qin M, Wong A, Seguin D, Gerlai R (2014). Induction of social behavior in zebrafish: live versus computer animated fish as stimuli. Zebrafish 11: 185–197.
202. Ragozzino ME, Detrick S, Kesner RP (1999). Involvement of the prelimbic–infralimbic areas of the rodent prefrontal cortex in behavioral flexibility for place and response learning. J Neurosci 19: 4585–4594.
203. Ramesh T, Lyon AN, Pineda RH, Wang C, Janssen PM, Canan BD et al. (2010). A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Dis Model Mech 3: 652–662.
204. Rao KD, Alex A, Verma Y, Thampi S, Gupta PK (2009). Real-time in vivo imaging of adult Zebrafish brain using optical coherence tomography. J Biophotonics 2: 288–291.
205. Rauch SL, Whalen PJ, Shin LM, McInerney SC, Macklin ML, Lasko NB et al. (2000). Exaggerated amygdala response to masked facial stimuli in posttraumatic stress disorder: a functional MRI study. Biol Psychiatry 47: 769–776.
206. Renier C, Faraco JH, Bourgin P, Motley T, Bonaventure P, Rosa F et al. (2007). Genomic and functional conservation of sedative-hypnotic targets in the zebrafish. Pharmacogenet Genomics 17: 237–253.
207. Richendrfer H, Pelkowski SD, Colwill RM, Creton R (2012). On the edge: pharmacological evidence for anxiety-related behavior in zebrafish larvae. Behav Brain Res 228: 99–106.
208. Richetti S, Blank M, Capiotti K, Piato A, Bogo M, Vianna M et al. (2011). Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish. Behav Brain Res 217: 10–15.
209. Rihel J, Prober D, Arvanites A, Lam K, Zimmerman S, Jang S et al. (2010). Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 327: 348–351.
210. Rosemberg DB, Braga MM, Rico EP, Loss CM, Córdova SD, Mussulini BHM et al. (2012). Behavioral effects of taurine pretreatment in zebrafish acutely exposed to ethanol. Neuropharmacology 63: 613–623.
211. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A et al. (1993). Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362: 59–62.
212. Rossor MN, Iversen LL, Reynolds GP, Mountjoy CQ, Roth M (1984). Neurochemical characteristics of early and late onset types of Alzheimer's disease. Br Med J 288: 961–964.
213. Rowland LP, Shneider NA (2001). Amyotrophic lateral sclerosis. N Engl J Med 344: 1688–1700.
214. Saitsu H, Kato M, Mizuguchi T, Hamada K, Osaka H, Tohyama J et al. (2008). De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet 40: 782–788.
215. Sallinen J, Torkko V, Sundvik M, Reenila I, Khrustalyov D, Kaslin J et al. (2009). MPTP and MPP+ target specific aminergic cell populations in larval zebrafish. J Neurochem 108: 719–731.
216. Saus E, Brunet A, Armengol I, Alonso P, Crespo JM, Fernandez-Aranda F et al. (2010). Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients. J Psychiatr Res 44: 971–978.
217. Saverino C, Gerlai R (2008). The social zebrafish: behavioral responses to conspecific, heterospecific, and computer animated fish. Behav Brain Res 191: 77–87.
218. Schaffer AE, Eggens VRC, Caglayan AO, Reuter MS, Scott E, Coufal NG et al. (2014). CLP1 founder mutation links tRNA splicing and maturation to cerebellar development and neurodegeneration. Cell 157: 651–663.
219. Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014). Biological insights from 108 schizophrenia-associated genetic loci. Nature 511: 421–427.
220. Schobel SA, Chaudhury NH, Khan UA, Paniagua B, Styner MA, Asllani I et al. (2013). Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron 78: 81–93.
221. Seibt KJ, da Luz Oliveira R, Bogo MR, Senger MR, Bonan CD (2015). Investigation into effects of antipsychotics on ectonucleotidase and adenosine deaminase in zebrafish brain. Fish Physiol Biochem 41: 1383–1392.
222. Seibt KJ, da Luz Oliveira R, Zimmermann FF, Capiotti KM, Bogo MR, Ghisleni G et al. (2010). Antipsychotic drugs prevent the motor hyperactivity induced by psychotomimetic MK-801 in zebrafish (Danio rerio). Behav Brain Res 214: 417–422.
223. Seibt KJ, Piato AL, da Luz Oliveira R, Capiotti KM, Vianna MRM, Bonan CD (2011). Antipsychotic drugs reverse MK-801-induced cognitive and social interaction deficits in zebrafish (Danio rerio). Behav Brain Res 224: 135–139.
224. Seligman ME, Beagley G (1975). Learned helplessness in the rat. J Comp Physiol Psychol 88: 534–541.
225. Seligman ME, Rosellini RA, Kozak MJ (1975). Learned helplessness in the rat: time course, immunization, and reversibility. J Comp Physiol Psychol 88: 542–547.
226. Selkoe DJ (2001). Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81: 741–766.
227. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ, Tonegawa S (1997). Skeletal and CNS defects in presenilin-1-deficient mice. Cell 89: 629–639.
228. Shin LM, Rauch SL, Pitman RK (2006). Amygdala, medial prefrontal cortex, and hippocampal function in PTSD. Ann N Y Acad Sci 1071: 67–79.
229. Smith SM, Vale WW (2006). The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stress. Dialogues Clin Neurosci 8: 383–395.
230. Southan C, Sharman JL, Benson HE, Faccenda E, Pawson AJ, Alexander SP et al. (2016). The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. Nucl Acids Res 44: D1054–D1068.
231. Spencer JP (2008). Food for thought: the role of dietary flavonoids in enhancing human memory, learning and neuro-cognitive performance. Proc Nutr Soc 67: 238–252.
232. Stein MB, Goldin PR, Sareen J, Zorrilla LT, Brown GG (2002). Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry 59: 1027–1034.
233. Stewart AM, Braubach O, Spitsbergen J, Gerlai R, Kalueff AV (2014a). Zebrafish models for translational neuroscience research: from tank to bedside. Trends Neurosci 37: 264–278.
234. Stewart AM, Cachat J, Gaikwad S, Robinson KS, Gebhardt M, Kalueff AV (2013). Perspectives on experimental models of serotonin syndrome in zebrafish. Neurochem Int 62: 893–902.
235. Stewart AM, Gaikwad S, Kyzar E, Green J, Roth A, Kalueff AV (2012). Modeling anxiety using adult zebrafish: a conceptual review. Neuropharmacology 62: 135–143.
236. Stewart AM, Gerlai R, Kalueff AV (2015a). Developing higher-throughput zebrafish screens for in-vivo CNS drug discovery. Front Behav Neurosci 9: 14.
237. Stewart AM, Grieco F, Tegelenbosch RA, Kyzar EJ, Nguyen M, Kaluyeva A et al. (2015b). A novel 3D method of locomotor analysis in adult zebrafish: Implications for automated detection of CNS drug-evoked phenotypes. J Neurosci Methods 255: 66–74.
238. Stewart AM, Grossman L, Nguyen M, Maximino C, Rosemberg DB, Echevarria DJ et al. (2014b). Aquatic toxicology of fluoxetine: understanding the knowns and the unknowns. Aquat Toxicol (Amsterdam, Netherlands) 156: 269–273.
239. Stewart AM, Ullmann JFP, Norton WHJ, Parker MO, Brennan CH, Gerlai R et al. (2015c). Molecular psychiatry of zebrafish. Mol Psychiatry 20: 2–17.
240. Stewart AM, Wong K, Cachat JM, Gaikwad S, Kyzar E, Wu N et al. (2011). Zebrafi sh models to study drug abuse-related phenotypes. Rev Neurosci 22: 95–105.
241. Strüber N, Strüber D, Roth G (2014). Impact of early adversity on glucocorticoid regulation and later mental disorders. Neurosci Biobehav Rev 38: 17–37.
242. Swain H, Sigstad C, Scalzo FM (2004). Effects of dizocilpine (MK-801) on circling behavior, swimming activity, and place preference in zebrafish (Danio rerio). Neurotoxicol Teratol 26: 725–729.
243. Swerdlow NR, Geyer MA, Braff DL (2001). Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology (Berl) 156: 194–215.
244. Teng Y, Xie X, Walker S, Rempala G, Kozlowski D, Mumm J et al. (2010). Knockdown of zebrafish Lgi1a results in abnormal development, brain defects and a seizure-like behavioral phenotype. Hum Mol Genet 19: 4409–4420.
245. Tran S, Chatterjee D, Gerlai R (2015). An integrative analysis of ethanol tolerance and withdrawal in zebrafish (Danio rerio). Behav Brain Res 276: 161–170.
246. Tran S, Gerlai R (2013). Time-course of behavioural changes induced by ethanol in zebrafish (Danio rerio). Behav Brain Res 252: 204–213.
247. Tye KM, Deisseroth K (2012). Optogenetic investigation of neural circuits underlying brain disease in animal models. Nat Rev Neurosci 13: 251–266.
248. Ullmann JF, Cowin G, Kurniawan ND, Collin SP (2010). A three-dimensional digital atlas of the zebrafish brain. Neuroimage 51: 76–82.
249. Vaccaro A, Patten SA, Aggad D, Julien C, Maios C, Kabashi E et al. (2013). Pharmacological reduction of ER stress protects against TDP-43 neuronal toxicity in vivo. Neurobiol Dis 55: 64–75.
250. Vaccaro A, Patten SA, Ciura S, Maios C, Therrien M, Drapeau P et al. (2012). Methylene blue protects against TDP-43 and FUS neuronal toxicity in C. elegans and D. rerio. PLoS One 7: e42117.
251. Valdmanis PN, Rouleau GA (2008). Genetics of familial amyotrophic lateral sclerosis. Neurology 70: 144–152.
252. Vatine G, Vallone D, Gothilf Y, Foulkes N (2011). It's time to swim! Zebrafish and the circadian clock. FEBS Lett 4: 19.
253. Voisin T, Vellas B (2009). Diagnosis and treatment of patients with severe Alzheimer's disease. Drugs Aging 26: 135–144.
254. von Trotha JW, Vernier P, Bally-Cuif L (2014). Emotions and motivated behavior converge on an amygdala-like structure in the zebrafish. Eur J Neurol 40: 3302–3315.
255. Wahbeh H, Kishiyama SS, Zajdel D, Oken BS (2008). Salivary cortisol awakening response in mild Alzheimer disease, caregivers, and noncaregivers. Alzheimer Dis Assoc Disord 22: 181–183.
256. Wang H (2008). Comparative analysis of Period genes in teleost fish genomes. J Mol Evol 67: 29–40.
257. Wang Y, Li S, Liu W, Wang F, Hu L-F, Zhong Z-M et al. (2016a). Vesicular monoamine transporter 2 (Vmat2) knockdown elicits anxiety-like behavior in zebrafish. Biochem Biophys Res Commun 470: 792–797.
258. Wang Y, Li S, Liu W, Wang F, Hu L-F, Zhong Z et al. (2016b). Vesicular monoamine transporter 2 (Vmat2) knockdown elicits anxiety-like behavior in zebrafish. Biochem Biophys Res Commun 470: 792–797.
259. Wang Y, Takai R, Yoshioka H, Shirabe K (2006). Characterization and expression of serotonin transporter genes in zebrafish. J Exp Med 208: 267–274.
260. WHO (2016). Epilepsy (Fact sheet No. 999). World Health Organization.
261. Wienholds E, van Eeden F, Kosters M, Mude J, Plasterk RHA, Cuppin E (2003). Efficient target-selected mutagenesis in zebrafish. Genome Res 13: 2700–2707.
262. Winter MJ, Redfern WS, Hayfield AJ, Owen SF, Valentin J-P, Hutchinson TH (2008). Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early stage development drugs. J Pharmacol Toxicol Methods 57: 176–187.
263. Wong K, Stewart AM, Gilder T, Wu N, Frank K, Gaikwad S et al. (2010). Modeling seizure-related behavioral and endocrine phenotypes in adult zebrafish. Brain Res 1348: 209–215.
264. Wulliman MF, Rupp B, Reichert H (2012). Neuroanatomy of the Zebrafish Brain: A Topological Atlas. Birkhäuser: Basel, Switzerland.
265. Wyart C, Del Bene F (2011). Let there be light: zebrafish neurobiology and the optogenetic revolution. Rev Neurosci 22: 121–130.
266. Wyatt C, Bartoszek EM, Yaksi E (2015). Methods for studying the zebrafish brain: past, present and future. Eur J Neurosci 42: 1746–1763.
267. Zdebik AA, Mahmood F, Stanescu HC, Kleta R, Bockenhauer D, Russell C (2013). Epilepsy in kcnj10 morphant zebrafish assessed with a novel method for long-term EEG recordings. PLoS One 8: e79765.
268. Zhang J, & Yuan Z (2015). In vivo non-invasive imaging of the adult zebrafish brain with a 1325 nm long range spectral-domain optical coherence tomography system.1–3.
269. Zhang S-W, Liu Y-X (2008). Changes of serum adrenocorticotropic hormone and cortisol levels during sleep seizures. Neurosci Bull 24: 84–88.
270. Zhdanova I (2006). Sleep in zebrafish. Zebrafish 3: 215–226.
271. Zhou QG, Zhu LJ, Wu HY, Luo CX, Chang L, Zhu DY (2011). Hippocampal neuronal nitric oxide synthase mediates the stress-related depressive behaviors of glucocorticoids by downregulating glucocorticoid receptor. J Neurosci 31: 7579–7590.
272. Ziv L, Muto A, Schoonheim PJ, Meijsing SH, Strasser D, Ingraham HA et al. (2013). An affective disorder in zebrafish with mutation of the glucocorticoid receptor. Mol Psychiatry 18: 681–691.
273. Zon LI (2014). Translational research: the path for bringing discovery to patients. Cell Stem Cell 14: 146–148.